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Case Report
Single-phase bilateral low dose
contrast medium injection for
diagnosing occlusions of the thoracic
venous system: a case report
Anders Svensson1,2 , Torkel B Brismar1,2 and
Fabian Morsbach1,2
Abstract
Occlusion of the thoracic venous system and/or occlusion of central venous catheters (CVC) of unknown cause can, in
selected cases, require advanced imaging. Here, we describe a case study of a patient with a failing central dialysis
catheter (CDC) which was diagnosed by computed tomography (CT) in connection with a single-phase bilateral low-
dose contrast medium (CM) injection using only 3.6 g of iodine. By injecting a low CM dose, the risk of streak artifacts
from first-pass of high intravascular concentrations of CM can be avoided. Therefore, the technique described here
should be beneficial also to patients with normal renal function.
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Introduction
Obstruction of the thoracic venous system can be due
to numerous reasons, for example thoracic malignan-
cies, especially lung cancer (1,2). Expansive tumor
growth leads to a narrowing and eventually total occlu-
sion of the superior vena cava (SVC). Failure of a cen-
tral line may also occur or exacerbate due to thrombus
formation in patients in patients with central venous
catheters (CVC) (3,4). Hence, an occlusion of a central
dialysis catheter (CDC) constitutes a potential medical
emergency. Diagnostic imaging for occlusions in
the thoracic venous system SVC syndrome include
contrast-enhanced computed tomography (CT), ultra-
sound/echo-cardiography, magnetic resonance imaging
(MRI), or conventional venograms (4).
However, imaging in some patient groups, e.g. in the
intensive care unit, may prove challenging. MRI
may be inaccessible and ultrasound inconclusive.
Furthermore, reduced kidney functions may be of con-
cern in case of CT, as those may need relatively
high iodine contrast media application for a complete
chest CT (4).
We present an imaging option for a CT venogram
with bilateral injection of low dose, diluted contrast
medium in a patient with unclear occlusion of a CDC
and failure to advance a new central catheter.
Case report
A 77-year-old male patient with biological aortic valve
and pronounced cardiovascular disease (atrial ﬁbrilla-
tion, pulmonary hypertension, dilated atriums, and
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mitral and tricuspid valve insuﬃciency) was referred to
the radiology department after inconclusive ultrasono-
graphic (US) Doppler of the thoracic venous system
after the patient’s current CDC had failed and a new
CDC was considered. Due to complete kidney failure
without any expected rest function, a protocol with
heavily reduced iodine content was developed. Here,
we present our thoracic CT venography protocol with
diluted contrast medium and bilateral intravenous
injection.
The CT scan was performed using a dual source
multidetector (MDCT) Somatom Deﬁnition Flash
(Siemens Healthcare, Forchheim, Germany). Scan par-
ameters included helical scanning using 128 0.6mm
detector collimation at a pitch of 0.9, 100 kVp, and
automatic tube current modulation. A simultaneous
intravenous bolus injection consisting of sodium chlor-
ide (NaCl) and contrast media (CM) solution
(Iomeprol 400mg iodine per mL, Bracco Imaging,
Milan, Italy) was performed using a dual head auto
injector (Medrad Stellant, Bayer, PA, USA). To
obtain an attenuation of 400 Hounsﬁeld units (HU)
in the central veins, it was assumed that the given
CM would be further diluted from blood at a ratio of
1:2 after the injection. The injected CM should
therefore have an attenuation of approximately
3 400¼ 1200HU. After analyzing the attenuation of
a set of CM dilutions in vitro (ranging from 200mg/mL
to 20mg/mL, data not shown), it was concluded that a
concentration of 40mg/I mL results in roughly 1200
HU and should be optimal. Thus, each syringe was
ﬁlled with a solution consisting of 90mL NaCl and
10mL CM, resulting in the desired concentration of
40mg/I mL. Of that solution, 45mL was injected
from each syringe through an 18-gauge percutaneous
venous catheter (PVC) applied in both left and right
medial cubital vein giving a total dosage of 3.6 g
iodine. Scan delay was set to 12 s.
Images were reconstructed with 0.75-mm slice thick-
ness and 0.7-mm reconstruction increment. All recon-
structed images series were sent to a dedicated
workstation (Advantage Work Station 4.6, GE
Healthcare, Milwaukee, WI, USA) for 3D volume ren-
dering (VR) post-processing.
The CT scan showed occlusion of the right sub-
clavian vein along with collateral vessels ending in the
SVC. On the left side, there was an elongated stenosis
of the brachiocephalic vein along with abundant collat-
eral vessels (Fig. 1–5).
Discussion
To visualize the central veins, we used 3.6 g iodine,
which is approximately a 90% reduction from the
clinical CM individualized standard CT protocol
(up to 500mg iodine per kg body weight) (6).
Contrast-induced acute kidney injury (CI-AKI) is
considered a complication to the use of CM. The
widely used deﬁnition of CI-AKI is an increase in
serum creatinine of 25%, or 44 mmol/L, from baseline
within 72 h after the administration of intravascular
CM. The complication predominantly aﬀects patients
with reduced renal function. In clinical practice, it is
considered that the risk of kidney damage increases
with the dose of injected CM (7). Therefore, in dialysis
patients with residual renal function, it is important to
Fig. 1. Sagittal-oblique reconstruction with visualization of the
hypodense thrombus (arrow A) associated with the catheter’s tip
(arrow B).
Fig. 2. Coronal MIP of the right subclavian vein with thrombus
material (arrow A) and total occlusion of the subclavian vein
proximally (arrow B).
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minimize the use of CM to preserve kidney residual
function. Although we injected a 10% CM solution,
which in total contained only 3.6 g iodine, the dilution
eﬀect in the vessels was smaller than expected and an
attenuation of approximately 900 HU was obtained in
the central veins. This indicates that the CM could be
further diluted, reducing the total CM dosage even
more. In theory, to achieve 400 HU the dose could be
halved, but there will be individual variations due to
regional blood ﬂow. Further studies reﬁning the concen-
tration of the injected CM should be performed in those
patients where a repeated CM injection would be of less
risk of CI-AKI. By injecting a low CM dose, the risk of
streak artifacts from ﬁrst-pass of high intravascular con-
centrations of CM (8) can be avoided. The technique
described in this case report should therefore be beneﬁ-
cial also to patients with normal renal function.
There are several non-invasive techniques to evalu-
ate the SVC. The simplest to the patient is US Doppler.
However, US Doppler is user-dependent, and the lack
of images is easy to interpret as the clinician makes
alternative imaging and diagnostic techniques desir-
able. Magnetic resonance angiography is an appealing
alternative, but the risk of necrotizing systemic ﬁbrosis
in patients with severe renal failure and scanner avail-
ability limits its use (9). Standard CT with intravenous
CM is another alternative. However, in patients
with renal impairment, this implies an increased risk
of CI-AKI.
In cases where patients have limited imaging options
or when other imaging options have failed, a CT veno-
gram with a total of >3.6 g iodine, bilaterally injected,
might be helpful as an additional way to determine
stenosis of the thoracic venous system, especially in
cases of suspected SVC syndrome. Furthermore, the
anatomical information from CT, including informa-
tion about collateral vessels, helps making the diagnosis
and would be of value to guide interventionalists when
planning treatment for the patient (5,10).
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Fig. 5. VR 3D image demonstrating proximal subtotal occlusion
of the left brachiocephalic vein (arrow A).
Fig. 4. Volume-rendered (VR) 3D image demonstrating com-
plete occlusion of the right subclavian vein (arrow A).
Fig. 3. Coronal MIP of the left brachiocephalic vein with
proximal occlusion (arrow).
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